Status: Recruiting
Detection and Prevention of Cancer-Related Cardiovascular Toxicity Registry
This study is being done in order to assess the cardiovascular events known as cardiovascular toxicity of chemotherapy agents and radiotherapy protocols in cancer subjects to identify risk prediction, prevention and treatment of cancer therapy-related cardiovascular toxicity and cancer therapy-related cardiac dysfunction
Participants needed: 10,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University of BolognaUpdated: Jun 19, 2025Locations: 5Duration: 3 Years
Eligibility criteria
Age 18 years old or older [+4]
Age <18 years old [+3]